-
·
Understanding MPNs: Expert Answers to Your Most Pressing Questions with Dr. Kristen Pettit
Tackle the complexity of MPNs with Dr. Kristen Pettit. Discover a grounded, honest approach to managing your condition and partnering with your care team.
-
·
Understanding MPN Biomarkers: JAK2, CALR, MPL & More
Andrew Schorr (MPN patient advocate) sits down with Dr. Angela Fleischman (University of California, Irvine) to unpack what JAK2, CALR, and MPL mean for MPN diagnosis and everyday care. They also explain how added findings (ASXL1, IDH1/2, EZH2), next-generation sequencing (NGS), and risk scores can inform treatment choices and clinical trials.
-
·
Your MPN, Your Journey: How New Discoveries Will Impact Personalized Care
Your MPN, Your Journey: How New Discoveries Will Impact Personalized Care Dr. John Mascarenhas of The Tisch Cancer Institute at Mount Sinai and patient advocate Andrew Schorr share the latest breakthroughs in MPN care.
-
·
Clinical Trials Update: What to Know in Myelofibrosis Care
Clinical Trials Update: What to Know in Myelofibrosis Care Following the American Society of Hematology Annual Meeting (ASH), Dr. Naveen Pemmaraju of MD Anderson and patient advocate Ruth Fein Revell discuss the latest myelofibrosis treatment options.
-
·
Myelofibrosis Clinical Trials and Latest Treatments
Clinical Trials and You: How to Navigate Treatment? Patient advocate Ruth Fein Revell, experts Dr. Angela Fleischman and Dr. Ruben Mesa, together with clinical trial nurse Melissa Melendez delve into the cutting-edge realm of myelofibrosis clinical trials.
-
·
The Latest in Myelofibrosis Treatments
The Latest in Myelofibrosis Treatments: What Clinical Trials are Available to Me? Myelofibrosis experts John Mascarenhas, MD, from Mount Sinai and Tania Jain, MBBS, from Johns Hopkins explain cutting-edge therapies. Clinical trial nurse Ashley Giacobbi and myelofibrosis patient advocate Mary Linde share powerful insights to help you navigate all aspects of clinical trials.
